MediXall Group, Inc.
MDXL
$0.0035
$0.00026.06%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 309.40K | 235.10K | 190.40K | 129.30K | 59.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 309.40K | 235.10K | 190.40K | 129.30K | 59.30K |
| Cost of Revenue | 1.24M | 1.45M | 1.50M | 2.03M | 3.20M |
| Gross Profit | -932.20K | -1.21M | -1.31M | -1.90M | -3.14M |
| SG&A Expenses | 2.98M | 3.18M | 3.30M | 3.31M | 3.36M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -180.50K | -180.50K | -180.50K | -180.50K |
| Total Operating Expenses | 4.23M | 4.45M | 4.61M | 5.16M | 6.38M |
| Operating Income | -3.92M | -4.21M | -4.42M | -5.03M | -6.32M |
| Income Before Tax | -4.56M | -4.89M | -5.07M | -5.64M | -6.83M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.56 | -4.89 | -5.07 | -5.64 | -6.83 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.56M | -4.89M | -5.07M | -5.64M | -6.83M |
| EBIT | -3.92M | -4.21M | -4.42M | -5.03M | -6.32M |
| EBITDA | -3.88M | -4.17M | -4.38M | -4.99M | -6.28M |
| EPS Basic | -0.04 | -0.04 | -0.04 | -0.05 | -0.06 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.03 | -0.04 |
| EPS Diluted | -0.04 | -0.05 | -0.05 | -0.05 | -0.06 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.03 | -0.04 |
| Average Basic Shares Outstanding | 510.65M | 499.09M | 485.49M | 474.19M | 466.63M |
| Average Diluted Shares Outstanding | 510.65M | 499.09M | 485.49M | 474.19M | 466.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
